Tradipitant for nausea from weight loss injections
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether the drug tradipitant can help reduce nausea and vomiting caused by weight loss injections like Ozempic or Wegovy. If you have these side effects and are not diabetic, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently taking a GLP-1 weight loss medication (like Ozempic, Wegovy, or Mounjaro) and have nausea or vomiting from it.
- You do not have type 1 or type 2 diabetes.
- Your body mass index (BMI) is between 25 and 40. This means you are in the overweight or obese range.
- You do not have other stomach or bowel problems that could cause nausea or vomiting.
- You have not had a bad reaction to certain nausea medications (NK-1 receptor antagonists) or GLP-1 medications before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This study tests a GLP-1 agonist medication (like Ozempic) to help postmenopausal women lose weight and improve physical and blood vessel health. It focuses on women aged 46–60 with obesity.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This trial tests if the weight-loss drug tirzepatide can help people with obesity-related endometrial cancer before their hysterectomy. It may improve surgical outcomes and overall health.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This trial tests a once-weekly injection that helps with weight loss and may improve the chances of a successful frozen embryo transfer in women with obesity. It aims to see if losing weight before the transfer leads to better pregnancy outcomes.
Hear when a new Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.